Aims: The aim of this study was to evaluate the efficacy and safety of radiofrequency thermocoagulation (RFT) combined with pulsed radiofrequency (PRF) of the Gasserian ganglion in patients with V2/V3 trigeminal neuralgia (TN).
Methods: We evaluated 27 patients with V2/3 TN who had undergone combined RFT and PRF of the Gasserian ganglion. Patients were treated with PRF (42°C, 45 V, 20 ms, 120 s), RFT (65°C, 60 s), RFT (70°C, 60 s), and PRF (42°C, 45 V, 20 ms, 120 s), consecutively. Visual analogue scale (VAS) and Barrow Neurological Institute Pain Intensity Scale (BNI) scores were evaluated before and after (1st month, 6th month, and 12th month) the procedure. A BNI score of 1-3 was considered as an effective treatment, while a BNI score of 4 or 5 indicated unsuccessful treatment.
Results: VAS scores were significantly lower than the baseline values in all post-treatment evaluation visits (1st month, 6th month, 12th month) during the 12-month follow-up period (p<0.001). After treatment, 26 patients (96.2%) at 1 month, 25 patients (92.5%) at 6 months, and 20 patients (74%) at 12 months had BNI scores of 1-3. No association was found between improvement in BNI and variables such as age, gender, duration of pain, TN side, affected branch, or pre-treatment VAS scores (p>0.05).
Conclusion: Combined RFT and PRF to the Gasserian ganglion is a safe and effective therapeutic approach in the treatment of TN. However, its efficacy partially decreases after one year.
Trigeminal neuralgia Gasserian ganglion pulse radiofrequency radiofrequency thermocoagulation
Amaç: V2/V3 trigeminal nevraljide (TN) gasser gangliona radyofrekans termokoagülasyonun (RFT) pulse radyofrekans (PRF) ile kombine olarak uygulanmasının etkililik ve güvenliğini değerlendirmek amaçlandı.
Gereç ve Yöntemler: Gasser gangliona kombine RFT ve PRF tedavisi uygulanmış 27 V2/3 TN'li hasta değerlendirildi. Hastalara sırasıyla PRF (42°C, 45V, 20 ms, 120 saniye), RFT (65 °C, 60 saniye), RFT (70 °C, 60 saniye), PRF (42°C, 45V, 20 ms, 120 saniye) uygulandı. Hastaların işlem öncesi ve sonrası (1.ay, 6. ay, 12. ay) Visual Analog Skala (VAS) ve Barrow Neurolgical Institute Ağrı Yoğunluk Skalası (BNI) skorları değerlendirildi. BNI skorunun 1 ila 3 arasında olması etkili tedavi olarak, BNI skorunun 4 ya da 5 olması ise başarısız tedavi olarak kabul edildi.
Bulgular: VAS skorları, 12 ay izlem dönemince tedavi sonrası tüm değerlendirme sürelerinde (1. ay, 6. ay, 12. ay) başlangıç değerine kıyasla anlamlı olarak daha düşüktü (p<0,001). Tedavi sonrası 1. ayda 26 hasta (% 96,2), 6. ayda 25 (% 92,5) hasta, 12. ayda 20 (%74) hastanın BNI skorları 1-3 arasında idi. BNI'deki iyileşme ile yaş, cinsiyet, ağrı süresi, TN tarafı, etkilenen dal ve işlem öncesi VAS skoru arasında bir ilişki bulunamadı. (p>0,05).
Sonuç: Gasser gangliona uygulanan kombine RFT+PRF TN tedavisinde güvenli ve etkili bir tedavidir. Ancak tedaviden 1 yıl sonra tedavinin etkinliği kısmen azalır.
Primary Language | English |
---|---|
Subjects | Neurology and Neuromuscular Diseases, Health Care Administration |
Journal Section | Research Articles [en] Araştırma Makaleleri [tr] |
Authors | |
Publication Date | August 30, 2023 |
Published in Issue | Year 2023 Volume: 4 Issue: 4 |
TR DİZİN ULAKBİM and International Indexes (1d)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.
EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation.
Journal articles are evaluated as "Double-Blind Peer Review".